Borassus palm (Borassus flabellifer), commonly known as Palmyra palm, has been used in traditional medicine in South and Southeast Asia for various ailments, including liver disorders such as hepatitis. Historical records and ethnobotanical surveys indicate that different parts of the palm—especially the fruit, sap, and roots—are utilized in folk remedies for their purported hepatoprotective (liver-protecting) effects. These uses are primarily based on longstanding traditional practices rather than robust clinical trials.

Scientific studies investigating the efficacy of Borassus palm for hepatitis are limited. Some in vitro and animal studies have demonstrated antioxidant and mild hepatoprotective properties of extracts from Borassus flabellifer, suggesting possible mechanisms that could be beneficial for liver health. However, these findings are preliminary, and there is a lack of well-designed human clinical trials specifically evaluating its impact on hepatitis or liver inflammation.

In summary, the use of Borassus palm for hepatitis is justified by traditional medicinal practices, with limited but suggestive preclinical evidence. However, the scientific validation is insufficient at present, and further research is needed to substantiate these traditional claims with rigorous clinical data.